Clinical Trials · NCT01767389
Glucagon-like Peptide (GLP) Utilization and Safety
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- GlaxoSmithKline
- Enrollment
- 1
- Start date
- Sep 2012
- Locations
- See registry
- Primary endpoint
- For treatment utilization patterns: adherence will be assessed.